This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Descartes Systems (DSGX) Lags Q3 Earnings Estimates
by Zacks Equity Research
Descartes Systems (DSGX) delivered earnings and revenue surprises of -4.55% and 3.54%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
Synopsys to Report Q4 Earnings: What's in Store for the Stock?
by Zacks Equity Research
SNPS' Q4 performance is likely to have reflected the benefits of advanced technology innovations propelled by its strong IP, designs and security solutions.
Synopsys (SNPS) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Synopsys (SNPS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2024.
Synopsys (SNPS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Synopsys (SNPS) concluded the recent trading session at $561.87, signifying a -0.57% move from its prior day's close.
Investors Heavily Search Synopsys, Inc. (SNPS): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Synopsys (SNPS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Wall Street Analysts Think Synopsys (SNPS) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Synopsys (SNPS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Synopsys (SNPS) Laps the Stock Market: Here's Why
by Zacks Equity Research
Synopsys (SNPS) closed the most recent trading day at $523.79, moving +0.58% from the previous trading session.
Can CDNS Stock Sustain its Rally After Gaining 12% in a Month?
by Vaishali Doshi
Robust end-market demand and opportunities presented by the rapid proliferation of AI are positives for Cadence but the external risks warrant caution.
Is Synopsys Stock a Buy, Sell or Hold at a P/E Multiple of 37.76X?
by Anirudha Bhagat
With slowing growth and rising competition, Synopsys' premium valuation raises concerns. Here's why selling SNPS stock might be wise now.
Synopsys (SNPS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
The latest trading day saw Synopsys (SNPS) settling at $556.26, representing a -0.94% change from its previous close.
Synopsys, Inc. (SNPS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Synopsys (SNPS). This makes it worthwhile to examine what the stock has in store.
Synopsys (SNPS) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Synopsys (SNPS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Synopsys (SNPS) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
In the most recent trading session, Synopsys (SNPS) closed at $518.40, indicating a +0.93% shift from the previous trading day.
Why the Market Dipped But Synopsys (SNPS) Gained Today
by Zacks Equity Research
Synopsys (SNPS) closed the most recent trading day at $501.58, moving +1.28% from the previous trading session.
Synopsys (SNPS) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the latest trading session, Synopsys (SNPS) closed at $495.25, marking a +0.37% move from the previous day.
Synopsys, Inc. (SNPS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Synopsys (SNPS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Top Analyst Reports for SAP, Goldman Sachs & Lockheed Martin
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), The Goldman Sachs Group, Inc. (GS) and Lockheed Martin Corp. (LMT), as well as two micro-cap stocks AMREP Corp. (AXR) and Nova LifeStyle, Inc. (NVFY).
Synopsys (SNPS) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the latest trading session, Synopsys (SNPS) closed at $507.03, marking a +0.46% move from the previous day.
Synopsys (SNPS) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Synopsys (SNPS) closed at $504.86 in the latest trading session, marking a +0.7% move from the prior day.
Want Better Returns? Don?t Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Synopsys (SNPS) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Synopsys (SNPS) settling at $539.92, representing a +1.28% change from its previous close.
Is Cadence's Acquisition Strategy Headed in the Right Direction?
by Zacks Equity Research
CDNS' inorganic expansion approach has played a pivotal part in developing the company's business in the last few years
Synopsys (SNPS) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
The latest trading day saw Synopsys (SNPS) settling at $533.08, representing a +0.77% change from its previous close.
Wall Street Analysts See Synopsys (SNPS) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Synopsys (SNPS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Synopsys, Inc. (SNPS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Synopsys (SNPS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.